EGFR and lung carcinoma: Recapitulation of EGFR mutations in lung cancer cells in vitro have demonstrated that it is an example of an 'oncogenic addiction' mutation which provides a biologic explanation for the improved outcome seen in this EGFR mutant NSCLC group relative to the wild type group[9].